Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Apache Livy.

This issue affects Apache Livy: from 0.3.0 before 0.9.0.

The vulnerability can only be exploited with non-default Apache Livy Server settings. If the configuration value "livy.file.local-dir-whitelist" is set to a non-default value, the directory checking can be bypassed.

Users are recommended to upgrade to version 0.9.0, which fixes the issue.

Project Subscriptions

No data.

Advisories

No advisories yet.

Fixes

Solution

No solution given by the vendor.


Workaround

No workaround given by the vendor.

History

Fri, 13 Mar 2026 20:00:00 +0000

Type Values Removed Values Added
References

Fri, 13 Mar 2026 19:15:00 +0000

Type Values Removed Values Added
Metrics cvssV3_1

{'score': 6.3, 'vector': 'CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L'}

ssvc

{'options': {'Automatable': 'no', 'Exploitation': 'none', 'Technical Impact': 'partial'}, 'version': '2.0.3'}


Fri, 13 Mar 2026 15:30:00 +0000

Type Values Removed Values Added
Description Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Apache Livy. This issue affects Apache Livy: from 0.3.0 before 0.9.0. The vulnerability can only be exploited with non-default Apache Livy Server settings. If the configuration value "livy.file.local-dir-whitelist" is set to a non-default value, the directory checking can be bypassed. Users are recommended to upgrade to version 0.9.0, which fixes the issue.
Title Apache Livy: Unauthorized directory access
Weaknesses CWE-22
References

Projects

Sign in to view the affected projects.

cve-icon MITRE

Status: PUBLISHED

Assigner: apache

Published:

Updated: 2026-03-13T18:11:59.840Z

Reserved: 2025-11-25T20:04:17.179Z

Link: CVE-2025-66249

cve-icon Vulnrichment

Updated: 2026-03-13T16:13:45.211Z

cve-icon NVD

Status : Received

Published: 2026-03-13T19:53:52.757

Modified: 2026-03-13T19:53:52.757

Link: CVE-2025-66249

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.

Weaknesses